Macrogenics (MGNX) Cash from Financing Activities (2012 - 2026)

Macrogenics' (MGNX) quarterly Cash from Financing Activities came in at -$207000.0 in Q1 2026, up 26.6% year-on-year from -$163512.6 in Q1 2025, and down 463.16% on a QoQ basis from $57000.0 in Q4 2025.

Macrogenics (MGNX) Cash from Financing Activities (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has 15 years of Cash from Financing Activities data on file, last reported at -$207000.0 in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 26.6% year-over-year to -$207000.0 in Q1 2026; TTM through Mar 2026 was $69.6 million, a 16083.49% increase from a year earlier, with the FY2025 full-year figure at $69.5 million, up 7141.04% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$207000.0, down from $57000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for MGNX reached as high as $100.1 million in Q1 2023 and fell as low as -$282000.0 in Q1 2025.
  • Historically, Cash from Financing Activities has averaged $14.8 million across 5 years, with a median of $248000.0 in 2024.
  • Across the five-year window, Cash from Financing Activities jumped 270489.19% in 2023 and sank 213.71% in 2025, its largest moves.
  • Year by year, Cash from Financing Activities stood at $1.4 million in 2022, then plunged by 79.91% to $273000.0 in 2023, then sank by 43.22% to $155000.0 in 2024, then tumbled by 63.23% to $57000.0 in 2025, then tumbled by 463.16% to -$207000.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$207000.0 in Q1 2026, $57000.0 in Q4 2025, and $69.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Macrogenics 254.43 Mn 187.92 Mn - -207,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -207,000.00
Mar 31, 2026 -207,000.00
Dec 31, 2025 57,000.00
Dec 31, 2025 57,000.00
Jun 30, 2025 69.74 Mn
Jun 30, 2025 69.74 Mn
Mar 31, 2025 -282,000.00
Mar 31, 2025 -282,000.00
Dec 31, 2024 155,000.00
Dec 31, 2024 155,000.00
Sep 30, 2024 -68,000.00
Sep 30, 2024 -68,000.00
Jun 30, 2024 625,000.00
Jun 30, 2024 625,000.00
Mar 31, 2024 248,000.00
Mar 31, 2024 248,000.00
Dec 31, 2023 273,000.00
Dec 31, 2023 273,000.00
Sep 30, 2023 49.91 Mn
Sep 30, 2023 49.91 Mn